About PAVmed, Inc. 
PAVmed, Inc.
Pharmaceuticals & Biotechnology
PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does not have an indwelling intravascular component. CarpX is a percutaneous device to treat carpal tunnel syndrome. NextCath is a self-anchoring catheter, which does not require suturing, traditional anchoring techniques or add-on catheter securement devices. The Company's DisappEAR is an Antibiotic-eluting Resorbable Ear Tubes. The Company is engaged in developing and commercializing antibiotic-eluting resorbable ear tubes based on an aqueous silk technology conceived and developed at these institutions. The Company is engaged in developing disposable infusion system with variable flow resistors. Caldus is a disposable tissue ablation device.
Company Coordinates 
Company Details
1 Grand Central Terminal Ste 4600 , NEW YORK NY : 10017-5743
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (3.43%)
Foreign Institutions
Held by 6 Foreign Institutions (0.23%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Lishan Aklog
Chairman of the Board, Chief Executive Officer
Mr. Michael Glennon
Independent Vice Chairman of the Board
Dr. David Battleman
Independent Director
Dr. James Cox
Independent Director
Mr. Ronald Sparks
Independent Director
Mr. David Weild
Independent Director
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-12 Million
Pharmaceuticals & Biotechnology
USD 9 Million (Micro Cap)
0.00
NA
0.00%
0.08
136.75%
0.23






